Company Research Report: Thess Corporate

Company Overview

• Name: Thess Corporate

• Mission: To innovate in the healthcare sector with solutions that enhance medical adherence and remote monitoring.

• Founded: No information is available.

• Founders: No information is available.

• Key People:

• Roland Sicard - CEO / Directeur R&D

• Regis Tatala - Co-founder

• Béatrice Jacquemard - Secretary General

• Clément Sicard - Chief Product Officer / Operations Manager

• Yves Boge - Head of New Technologies and Industrialization

• Christian Mercier - Coordination Director

• Caroline Saudemon - Quality and Regulatory Manager

• Pascal Gerbaud - Commercial Director

• Headquarters: No information is available.

• Number of Employees: No information is available.

• Revenue: No information is available.

• What the Company is Known For: Thess is recognized for its contribution to healthcare technology with innovative solutions like the Therapy Smart System and Thess Monitoring systems, focusing on medical adherence and remote medical surveillance.

Products

Therapy Smart System

• Description: A connected and secure medical device for medication adherence.

• Key Features:

• Monitors adherence and ensures secure medication intake.

• Supports decentralized studies for reliable monitoring of medication adherence.

• Ensures personalized medicine through adapted therapeutic protocols.

• Real-time alerts for missed doses to caregivers or family members via SMS/email.

Thess Monitoring

• Description: A medical device for remote patient monitoring, especially for nephrology, surgery, and oncology.

• Key Features:

• Undergoing CE certification as a Class IIa medical device.

• Automatic retrieval of biological results from local laboratories.

• Comprehensive remote monitoring tool for decentralized clinical trials.

• Configurable electronic patient-related outcomes (e-PRO).

• Detection of symptoms/adverse effects through questionnaires, with notification system.

• Supports clinical monitoring and patient care pathways by connecting patients with care teams.

Recent Developments

• Recent Developments in the Company:

• Thess Corporate is recognized among the new industrial unicorns in France.

• Participated in the fourth cohort of the Néo Accelerator by the public investment bank, receiving advisory services and networking opportunities.

• New Products Launched: No information is available.

• New Features Added to Existing Products: No specific new features have been detailed beyond current key features.

• New Partnerships: No information is available.

Additional Information

• Thess's project has been funded under the France 2030 industrialization and export initiative, as well as the European Union's Next Generation EU under the France Relance plan.

• The company is identified as one of the top 11 cancer-related companies and startups in France for 2024.

• Participation in upcoming event: SantExpo, 21-23 May 2024, Paris, Porte de Versailles, Stand P16.